Lotus Pharm vs EirGenix: monthly revenue

Monthly revenue and year-on-year change for Lotus Pharm (1795) and EirGenix (6589) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ Lotus Pharm ━ EirGenix

0%+288%-22%25/1026/0126/0426/0726/10

Monthly revenue history

MonthLotus PharmYoYEirGenixYoY
Oct 2026NT$2.13 billion-22.5%NT$271.7 million+287.9%
Sep 2026NT$2.77 billion+128.0%NT$117.3 million+43.2%
Aug 2026NT$2.11 billion+81.7%NT$163.7 million+125.9%
Jul 2026NT$2.49 billion+3.9%NT$211.8 million+184.0%
Jun 2026NT$3.4 billion+225.5%NT$113.3 million+94.3%
May 2026NT$2.32 billion+105.8%NT$116.8 million+56.3%
Apr 2026NT$3.09 billion+19.9%NT$82.2 million-15.8%
Mar 2026NT$4.35 billion+173.6%NT$114.7 million+28.2%
Feb 2026NT$2.24 billion+131.5%NT$85 million+100.6%
Jan 2026NT$2.05 billion-5.5%NT$108.8 million+117.1%
Dec 2025NT$2.44 billion+66.9%NT$157.8 million+14.0%
Nov 2025NT$1.06 billion-0.2%NT$135.8 million+41.6%
Oct 2025NT$2.75 billion+46.0%NT$70 million+16.1%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16